| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer
|
Chang, Elaine
|
|
|
|
3 |
p. 271-286
|
artikel
|
| 2 |
A Gene Expression Signature Predicts Bladder Cancer Cell Line Sensitivity to EGFR Inhibition
|
Goodspeed, Andrew
|
|
2018
|
|
3 |
p. 269-282
|
artikel
|
| 3 |
Alternating Cystoscopy with Bladder EpiCheck® in the Surveillance of Low-Grade Intermediate-Risk NMIBC: A Cost Comparison Model
|
Lotan, Yair
|
|
|
|
3 |
p. 307-315
|
artikel
|
| 4 |
Antibody-Drug Conjugates in Bladder Cancer
|
Vlachostergios, Panagiotis J.
|
|
2018
|
|
3 |
p. 247-259
|
artikel
|
| 5 |
A Randomized Feasibility Trial Comparing Surveillance Regimens for Patients with Low and Low-Intermediate Risk Non-Muscle Invasive Bladder Cancer
|
Reyes, Ryan M.
|
|
|
|
3 |
p. 285-295
|
artikel
|
| 6 |
Assessing Symptom Burden in Bladder Cancer: An Overview of Bladder Cancer Specific Health-Related Quality of Life Instruments
|
Danna, Bernard J.
|
|
2016
|
|
3 |
p. 329-340
|
artikel
|
| 7 |
A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder Cancer
|
D’Costa, Jamie J.
|
|
2016
|
|
3 |
p. 301-317
|
artikel
|
| 8 |
Automated Urinalysis Machines: Potential Impact on the Diagnosis of Bladder Cancer
|
Messing, Edward
|
|
|
|
3 |
p. 249-250
|
artikel
|
| 9 |
Basal and Luminal Molecular Subtypes in Naturally-Occurring Canine Urothelial Carcinoma are Associated with Tumor Immune Signatures and Dog Breed
|
Sommer, Breann C.
|
|
|
|
3 |
p. 317-333
|
artikel
|
| 10 |
Beyond Cisplatin – I
|
Messing, Edward M.
|
|
2016
|
|
3 |
p. 365-367
|
artikel
|
| 11 |
Challenging Cases in Urothelial Cancer
|
Soloway, Mark S.
|
|
2017
|
|
3 |
p. 225-226
|
artikel
|
| 12 |
Challenging Cases in Urothelial Cancer
|
Soloway, Mark S.
|
|
2018
|
|
3 |
p. 343-345
|
artikel
|
| 13 |
Challenging Cases in Urothelial Cancer
|
Soloway, Mark S.
|
|
|
|
3 |
p. 245-247
|
artikel
|
| 14 |
Challenging Cases in Urothelial Cancer: Case 171
|
Soloway, Mark S.
|
|
|
|
3 |
p. 393-394
|
artikel
|
| 15 |
Challenging Cases in Urothelial Cancer: Case 21
|
Soloway, Mark S.
|
|
|
|
3 |
p. 377-380
|
artikel
|
| 16 |
Challenging Cases in Urothelial Cancer: Case 25
|
Soloway, Mark S.
|
|
|
|
3 |
p. 329-333
|
artikel
|
| 17 |
Challenging Cases in Urothelial Cancer: Case 29
|
Soloway, Mark S.
|
|
|
|
3 |
p. 289-292
|
artikel
|
| 18 |
CIS of the Bladder: Significance and Implications for Therapy
|
Mirabal, Jorge Rivera
|
|
|
|
3 |
p. 193-204
|
artikel
|
| 19 |
Clinical Trials Corner
|
|
|
2016
|
|
3 |
p. 361-363
|
artikel
|
| 20 |
Clinical Trials Corner
|
Agarwal, Piyush K.
|
|
2018
|
|
3 |
p. 347-350
|
artikel
|
| 21 |
Clinical Trials Corner
|
Agarwal, Piyush K.
|
|
2017
|
|
3 |
p. 229-230
|
artikel
|
| 22 |
Clinical Trials Corner Issue 6(3)
|
Agarwal, Piyush K.
|
|
|
|
3 |
p. 395-398
|
artikel
|
| 23 |
Clinical Trials Corner Issue 7(3)
|
Agarwal, Piyush K.
|
|
|
|
3 |
p. 381-384
|
artikel
|
| 24 |
Comparison of Robotic vs Open Cystectomy: A Systematic Review
|
Sathianathen, Niranjan J.
|
|
|
|
3 |
p. 253-269
|
artikel
|
| 25 |
Current Management of Localized Muscle-Invasive Bladder Cancer: A Consensus Guideline from the Genitourinary Medical Oncologists of Canada
|
Jiang, Di Maria
|
|
|
|
3 |
p. 363-392
|
artikel
|
| 26 |
Diagnostic Performance of Novel Urine-Based mRNA Tests (Xpert and Urinary Metabolomics Markers Assay) for Bladder Cancer Detection in Patients with Hematuria
|
Elsawy, Amr A.
|
|
|
|
3 |
p. 319-328
|
artikel
|
| 27 |
Differences in Quality of Life Between Men and Women who Undergo Bladder Preservation with Trimodality Therapy
|
Ballas, Leslie K.
|
|
|
|
3 |
p. 279-284
|
artikel
|
| 28 |
Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder Cancer
|
Karsh, Lawrence
|
|
2018
|
|
3 |
p. 293-301
|
artikel
|
| 29 |
Editorial Concerning “Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy”
|
Shen, Steven
|
|
2017
|
|
3 |
p. 171-172
|
artikel
|
| 30 |
Efficacy of EGFR Inhibitors and NSAIDs Against Basal Bladder Cancers in a Rat Model: Daily vs. Weekly Dosing, Combining EGFR Inhibitors with Naproxen, and Effects on RNA Expression
|
Lubet, Ronald A.
|
|
|
|
3 |
p. 335-345
|
artikel
|
| 31 |
Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder Cancer
|
van Kessel, Kim E.M.
|
|
2016
|
|
3 |
p. 351-360
|
artikel
|
| 32 |
Erratum to: Total Fluid Intake and the Risk of Recurrence in Patients with Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study
|
Jochems, Sylvia H.J.
|
|
|
|
3 |
p. 401
|
artikel
|
| 33 |
Establishment of Real-Time Multispectral Imaging for the Detection of Bladder Cancer Using a Preclinical in Vivo Model
|
Meessen, Sabine
|
|
|
|
3 |
p. 285-294
|
artikel
|
| 34 |
Evaluation of a Novel Cystoscopic Compatible Cryocatheter for the Treatment of Bladder Cancer
|
Baust, John M.
|
|
|
|
3 |
p. 303-318
|
artikel
|
| 35 |
Fatty Acid Patterns Detected By Ambient Ionization Mass Spectrometry in Canine Invasive Urothelial Carcinoma From Dogs of Different Breeds
|
D’Hue, Cedric A.
|
|
2018
|
|
3 |
p. 283-291
|
artikel
|
| 36 |
Financial Toxicity of Having Bladder Cancer
|
Messing, Edward M.
|
|
2018
|
|
3 |
p. 351-352
|
artikel
|
| 37 |
Functional Outcomes After Robotic Radical Cystectomy with Intracorporeal Diversion: A Systematic Review
|
Daza, Jorge
|
|
|
|
3 |
p. 329-342
|
artikel
|
| 38 |
High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder Cancer
|
Kates, Max
|
|
2017
|
|
3 |
p. 191-199
|
artikel
|
| 39 |
Historical Pathogen-Driven Selection May Contribute to Contemporary Ethnic Difference in Bladder Cancer Susceptibility
|
Meng, Xiang-Yu
|
|
|
|
3 |
p. 211-216
|
artikel
|
| 40 |
Iatrogenic Causes of Urothelial Cancer of the Upper Urinary Tract and Bladder
|
Messing, Edward M.
|
|
|
|
3 |
p. 385-387
|
artikel
|
| 41 |
Image-Guided Transurethral Resection of Bladder Tumors – Current Practice and Future Outlooks
|
Chang, Timothy C.
|
|
2017
|
|
3 |
p. 149-159
|
artikel
|
| 42 |
Immune Checkpoint Inhibitors in Metastatic Bladder and Other Solid Malignancies: How Long is Enough?
|
Kumar, Vivek
|
|
|
|
3 |
p. 201-210
|
artikel
|
| 43 |
Impact of Adjuvant Gemcitabine Containing Chemotherapy Following Radical Nephroureterectomy for Patients with Upper Tract Urothelial Carcinoma: Results from a Propensity-Score Matched Cohort Study
|
Hongda, Zhao
|
|
|
|
3 |
p. 217-226
|
artikel
|
| 44 |
Impact of Facility Radiation Patient Volume on Overall Survival in Patients with Muscle Invasive Bladder Cancer Undergoing Trimodality Bladder Preservation Therapy
|
Fischer-Valuck, Benjamin W.
|
|
|
|
3 |
p. 235-244
|
artikel
|
| 45 |
Impact of Intestinal Urinary Diversion on the Risk of Fracture and Loss of Bone Mass: A Systematic Review
|
Pozo, Carmen
|
|
|
|
3 |
p. 365-376
|
artikel
|
| 46 |
Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy
|
Moschini, Marco
|
|
2017
|
|
3 |
p. 161-169
|
artikel
|
| 47 |
Increased Proliferation as Independent Predictor of Disease Recurrence in Initial Stage pTa Urothelial Bladder Cancer
|
Breyer, Johannes
|
|
2017
|
|
3 |
p. 173-180
|
artikel
|
| 48 |
Investigating the STING Pathway to Explain Mechanisms of BCG Failures in Non-Muscle Invasive Bladder Cancer: Prognostic and Therapeutic Implications
|
Koti, Madhuri
|
|
|
|
3 |
p. 225-234
|
artikel
|
| 49 |
Letter to the Editor: Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease
|
Li, Roger
|
|
2017
|
|
3 |
p. 147-148
|
artikel
|
| 50 |
LncRNA HEIH/miR-4500/IGF2BP1/c-Myc Feedback Loop Accelerates Bladder Cancer Cell Growth and Stemness
|
Guo, Baowei
|
|
|
|
3 |
p. 255-267
|
artikel
|
| 51 |
Loss of Cxcr2 in Myeloid Cells Promotes Tumour Progression and T Cell Infiltration in Invasive Bladder Cancer
|
Ismail, Nur Faezah Binti
|
|
|
|
3 |
p. 277-290
|
artikel
|
| 52 |
Low Frequency of Intratumor Heterogeneity in Bladder Cancer Tissue Microarrays
|
Jakobsson, Lovisa
|
|
2018
|
|
3 |
p. 327-337
|
artikel
|
| 53 |
Lung Metastases Versus Second Primary Lung Cancers in Patients with Primary Urothelial Carcinoma of the Bladder: A National Population-Based Assessment
|
Taylor, Jacob
|
|
|
|
3 |
p. 347-354
|
artikel
|
| 54 |
Mechanism of Sex Differences in Bladder Cancer: Evident and Elusive Sex-biasing Factors
|
Lam, Christa M.
|
|
|
|
3 |
p. 241-254
|
artikel
|
| 55 |
MHC I Expression Predicts Response to Checkpoint Inhibitors in Metastatic Urothelial Carcinoma but Lacks Prognostic Value in Localized Disease
|
Slotta-Huspenina, Julia
|
|
|
|
3 |
p. 269-276
|
artikel
|
| 56 |
Molecular/ Genetic/ Protein Characterizing of Bladder Cancer Circulating Tumor Cells
|
Seranio, Nicolas
|
|
|
|
3 |
p. 205-210
|
artikel
|
| 57 |
Muscle-Invasive Bladder Cancer in Patients with Liver Cirrhosis: A Review of Pertinent Considerations
|
Kim, John
|
|
|
|
3 |
p. 261-278
|
artikel
|
| 58 |
Mutational Analysis of Field Cancerization in Bladder Cancer
|
Strandgaard, Trine
|
|
|
|
3 |
p. 253-264
|
artikel
|
| 59 |
Mutations in Non-Tumoral Human Urothelium: Disease Prelude or Epilogue?
|
Piedrafita, Gabriel
|
|
|
|
3 |
p. 249-252
|
artikel
|
| 60 |
New Horizons in Bladder Cancer Research: Report of the 15th Meeting of the International Bladder Cancer Network (IBCN) in Lisbon, Portugal, October 21–23, 2017
|
Black, Peter C.
|
|
2018
|
|
3 |
p. 339-342
|
artikel
|
| 61 |
New Intravesical Agents for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer
|
Asimakopoulos, Anastasios D.
|
|
|
|
3 |
p. 237-251
|
artikel
|
| 62 |
New Salvage Treatments for Metastatic Bladder Cancer
|
Messing, Edward M.
|
|
|
|
3 |
p. 399-400
|
artikel
|
| 63 |
New Sister Journal Kidney Cancer
|
Lerner, Seth P.
|
|
2017
|
|
3 |
p. 143
|
artikel
|
| 64 |
Obesity and Outcomes in Patients with Metastatic Urothelial Carcinoma1
|
Leiter, Amanda
|
|
2016
|
|
3 |
p. 341-349
|
artikel
|
| 65 |
Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer
|
Kamat, Ashish M.
|
|
2017
|
|
3 |
p. 145-146
|
artikel
|
| 66 |
Open vs Robotic Surgery
|
Messing, Edward M.
|
|
|
|
3 |
p. 335-337
|
artikel
|
| 67 |
Optimizing Sequence of PD-L1 Immune-Checkpoint Inhibitors and Radiation Therapy in Bladder Cancer
|
Tholomier, Côme
|
|
|
|
3 |
p. 295-302
|
artikel
|
| 68 |
Outcomes of Patients with Bacillus Calmette-Guérin (BCG)-Unresponsive Non-Muscle Invasive Bladder Cancer as Defined by the U.S. Food and Drug Administration
|
Howard, Jeffrey M.
|
|
|
|
3 |
p. 303-314
|
artikel
|
| 69 |
PD-L1/PD-1 Biomarker for Metastatic Urothelial Cancer that Progress Post-platinum Therapy: A Systematic Review and Meta-analysis
|
Tan, Wei Phin
|
|
|
|
3 |
p. 211-223
|
artikel
|
| 70 |
Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium
|
Flaig, Thomas W.
|
|
2017
|
|
3 |
p. 211-223
|
artikel
|
| 71 |
Quality of Life and Anxiety in Patients with First Diagnosed Non-Muscle Invasive Bladder Cancer Who Receive Adjuvant Bladder Therapy
|
Vaioulis, Alexandros
|
|
|
|
3 |
p. 297-306
|
artikel
|
| 72 |
Radiation Therapy as Definitive Local Treatment in Patients with Limited-Stage Small Cell Carcinoma of the Bladder: Does total dose matter?
|
Germino, Elizabeth
|
|
2018
|
|
3 |
p. 311-317
|
artikel
|
| 73 |
Radiomics and Bladder Cancer: Current Status
|
Cacciamani, Giovanni E.
|
|
|
|
3 |
p. 343-362
|
artikel
|
| 74 |
Recurrence in Non-Muscle Invasive Bladder Cancer Patients: External Validation of the EORTC, CUETO and EAU Risk Tables and Towards a Non-Linear Survival Model
|
Lucas, Marit
|
|
|
|
3 |
p. 277-284
|
artikel
|
| 75 |
Review: Brain Metastases in Bladder Cancer
|
Brenneman, Randall J.
|
|
|
|
3 |
p. 237-248
|
artikel
|
| 76 |
Survival of Patients with Muscle-Invasive Urothelial Cancer of the Bladder with Residual Disease at Time of Cystectomy: A Comparative Survival Analysis of Treatment Modalities in the National Cancer Database
|
Pfail, John L.
|
|
|
|
3 |
p. 265-276
|
artikel
|
| 77 |
Systematic Review and Meta-Analysis on the Impact of Hexaminolevulinate- Versus White-Light Guided Transurethral Bladder Tumor Resection on Progression in Non-Muscle Invasive Bladder Cancer
|
Gakis, Georgios
|
|
2016
|
|
3 |
p. 293-300
|
artikel
|
| 78 |
Systematic Review and Meta-Analysis on the Role of Perioperative Blood Transfusion in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma
|
Kochergin, Maxim
|
|
|
|
3 |
p. 315-327
|
artikel
|
| 79 |
Systematic Review: An Update on the Spectrum of Urological Malignancies in Lynch Syndrome
|
Huang, Dora
|
|
2018
|
|
3 |
p. 261-268
|
artikel
|
| 80 |
Systematic Review: Depression and Anxiety Prevalence in Bladder Cancer Patients
|
Vartolomei, Liliana
|
|
2018
|
|
3 |
p. 319-326
|
artikel
|
| 81 |
The Antineoplastic Activity of Photothermal Ablative Therapy with Targeted Gold Nanorods in an Orthotopic Urinary Bladder Cancer Model
|
Yang, Xiaoping
|
|
2017
|
|
3 |
p. 201-210
|
artikel
|
| 82 |
The BCG Shortage
|
Messing, Edward M.
|
|
2017
|
|
3 |
p. 227-228
|
artikel
|
| 83 |
The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer
|
Douglass, Laura
|
|
2016
|
|
3 |
p. 285-292
|
artikel
|
| 84 |
The Impact of Dose Reduction of Bacillus Calmette–Guerin on Oncological Outcomes and Toxicity in Non-Muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
|
Azuri, Wadi
|
|
|
|
3 |
p. 227-236
|
artikel
|
| 85 |
The Impact of Physical Activity on Risk and Health-Related Quality of Life in Bladder Cancer
|
Rodríguez Cintas, Marina
|
|
|
|
3 |
p. 355-364
|
artikel
|
| 86 |
The Relationship between Centralization of Care and Geographic Barriers to Cystectomy for Bladder Cancer
|
Casey, Martin F.
|
|
2016
|
|
3 |
p. 319-327
|
artikel
|
| 87 |
The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness
|
Andolfi, Ciro
|
|
|
|
3 |
p. 225-235
|
artikel
|
| 88 |
Total Fluid Intake and the Risk of Recurrence in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study
|
Jochems, Sylvia H.J.
|
|
2018
|
|
3 |
p. 303-310
|
artikel
|
| 89 |
Urethral Melanoma – Clinical, Pathological and Molecular Characteristics
|
Mano, Roy
|
|
|
|
3 |
p. 291-301
|
artikel
|
| 90 |
Use of Adjuvant Chemotherapy in Patients with Advanced Bladder Cancer after Neoadjuvant Chemotherapy
|
Sui, Wilson
|
|
2017
|
|
3 |
p. 181-189
|
artikel
|
| 91 |
Y Chromosome Loss and Bladder Cancer
|
Messing, Edward M.
|
|
|
|
3 |
p. 287-288
|
artikel
|
Tijdschrift beschrijving